Japan Tissue Engineering Co., Ltd.
Q1 FY2026 Financial Results Explanation Material
Sales for the first quarter of Fiscal Year 2026 increased by 130% YoY, operating profit turned positive, and net assets grew to approximately 510 billion yen. Continued expansion of new products and businesses strengthens the growth foundation.
Key Figures
- Sales: 766 million yen (up 340 million yen YoY)
- Operating Income: 59 million yen (up 94 million yen YoY)
- Net Assets: 5,142 million yen (up 52 million yen from the previous period)
AI要約
Performance Overview
In the first quarter of FY2026, the Company achieved sales of 766 million yen (+130% YoY), operating profit of 59 million yen (turned positive compared to the same period last year), and net assets of 5,142 million yen (+52 million yen compared to the previous period). We are strengthening our revenue base and accelerating growth through new product launches and business expansion.
Future Outlook and Investor Impact
We will continue promoting new product development and business expansion, aiming to enhance profitability and financial stability. For investors, the sustained growth foundation and profitability improvement promise long-term value creation.
Sales Trend
Operating Income Trend
Japan Tissue Engineering Co., Ltd.
Company overview · Stock price · Financial data · All IR
